company background image
524494 logo

Ipca Laboratories BSE:524494 Stock Report

Last Price

₹1.17k

Market Cap

₹295.6b

7D

-2.0%

1Y

49.3%

Updated

18 Mar, 2024

Data

Company Financials +

Ipca Laboratories Limited

BSE:524494 Stock Report

Market Cap: ₹295.6b

524494 Stock Overview

Ipca Laboratories Limited, a pharmaceutical company, manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India.

524494 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth4/6
Past Performance2/6
Financial Health5/6
Dividends2/6

Rewards

Risk Analysis

No risks detected for 524494 from our risk checks.

Ipca Laboratories Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Ipca Laboratories
Historical stock prices
Current Share Price₹1,165.65
52 Week High₹1,264.00
52 Week Low₹670.00
Beta0.23
1 Month Change-6.10%
3 Month Change5.23%
1 Year Change49.28%
3 Year Change27.11%
5 Year Change153.84%
Change since IPO1,404.06%

Recent News & Updates

Recent updates

Shareholder Returns

524494IN PharmaceuticalsIN Market
7D-2.0%-1.6%-2.8%
1Y49.3%66.6%45.2%

Return vs Industry: 524494 underperformed the Indian Pharmaceuticals industry which returned 65.3% over the past year.

Return vs Market: 524494 exceeded the Indian Market which returned 44% over the past year.

Price Volatility

Is 524494's price volatile compared to industry and market?
524494 volatility
524494 Average Weekly Movement4.5%
Pharmaceuticals Industry Average Movement6.2%
Market Average Movement6.7%
10% most volatile stocks in IN Market10.2%
10% least volatile stocks in IN Market4.0%

Stable Share Price: 524494 has not had significant price volatility in the past 3 months.

Volatility Over Time: 524494's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
194916,167Pranay Godhahttps://www.ipca.com

Ipca Laboratories Limited, a pharmaceutical company, manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetology, dermatology, gastroenterology, hematology, neurology, ophthalmology, rheumatology, and urology, as well as psychiatry, probiotics, respiratory, orthopedics, oral anti diabetes drug, nutraceuticals, NSAIDs, neuropathic pain, malaria, infectious diseases, immunosuppressant, hepatoprotectives, helminthics, fever, and emollients/protectives.

Ipca Laboratories Limited Fundamentals Summary

How do Ipca Laboratories's earnings and revenue compare to its market cap?
524494 fundamental statistics
Market cap₹295.58b
Earnings (TTM)₹5.64b
Revenue (TTM)₹71.87b

52.4x

P/E Ratio

4.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
524494 income statement (TTM)
Revenue₹71.87b
Cost of Revenue₹26.97b
Gross Profit₹44.90b
Other Expenses₹39.26b
Earnings₹5.64b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)22.24
Gross Margin62.47%
Net Profit Margin7.85%
Debt/Equity Ratio26.3%

How did 524494 perform over the long term?

See historical performance and comparison

Dividends

0.2%

Current Dividend Yield

9%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.